Who We Are?
The Kuruom School of Advanced Sciences (KSAS), a subsidiary organization of the Institute of Advanced Sciences (INADS), is the latest initiative of the US-based Maryada Foundation and India-based Kuruom Foundation. Maryada Foundation’s goals are to propagate the principles of a service-based society in which the most accomplished serve the least evolved members of the society and the universe. Kuruom Foundation is a village-based charitable organization promoting the development of a village-based society for a sustainable world.
The KSAS will be a leading educational center for the creation of a vibrant research, scholarship, and teaching institution,
- To engage the academic and scholarly community,
- To develop fundamental practical knowledge for human self-reliance and planetary sustainability,
- To develop agricultural, artistic, and Ayurvedic technologies appropriate for rural development,
- Promoting holistic education, and
- Develop into an advanced research center involved in basic and applied research.
The Kuruom School of Advanced Sciences (KSAS) is advancing an integrated portfolio of research programs spanning therapeutic biomolecules, cancer biology, vaccine design, and neuronal repair. These initiatives reflect a commitment to developing molecularly precise and clinically translatable interventions for diseases underserved by conventional therapies. By combining biotechnology with systems-level approaches, KSAS is building platforms that merge mechanistic insight with therapeutic innovation, positioning itself at the forefront of translational biomedical science.
In immunotherapy, KSAS is engineering highly selective monoclonal and bispecific antibodies, while collaborating with the Institute of Advanced Sciences (INADS), USA, to design next-generation protein-based vaccines. Unlike nucleic acid vaccines, these protein formulations offer durable protection without the risks associated with genomic integration. The institute is also pioneering cancer reprogramming strategies aimed at reverting malignant phenotypes with minimal systemic toxicity, alongside advancing CAR-T–based therapies for autoimmune disorders. To support these pipelines, KSAS is optimizing expression vectors and protein production systems for scalable, high-fidelity synthesis of biologics.
In neuroscience, KSAS is developing dual strategies for central nervous system repair, enhancing intrinsic axonal growth and remyelination while suppressing inhibitory signals, using fusion proteins, viral vectors, and nanocarriers. Parallel efforts target complement-mediated synaptic pruning to mitigate neurodegeneration. Together, these multidisciplinary programs chart a path toward safer, more effective therapies across oncology, immunology, and neurology.
KSAS Symposium 2026 - The International Symposium on Cognitive Biology
Theme - Cognition Across Life: From Cells to Consciousness
Proposed Date - February 6-8, 2026
Venue - Kuruom School of Advanced Sciences Research Center, Lucknow (Hybrid)
